THE ANTITUMOR-ACTIVITY AND IMMUNOSUPPRESSIVE EFFECTS OF 5-FLUOROURACIL SUPPOSITORIES IN RECTAL-CANCER PATIENTS

被引:5
|
作者
ADACHI, W
SUGENOYA, A
HORIGOME, N
TAKAHASHI, C
IIDA, F
NAKAYAMA, J
机构
[1] Department of Surgery, Shinshu University School of Medicine, Nagano, 390
[2] Central Clinical Laboratories, Shinshu University Hospital, Matsumoto
来源
关键词
5FU SUPPOSITORY; RECTAL CANCER; TISSUE CONCENTRATION OF 5FU; LYMPHOCYTE SUBSET OF REGIONAL LYMPH NODES;
D O I
10.1007/BF00308826
中图分类号
R61 [外科手术学];
学科分类号
摘要
The antitumor activity and immunological effects of the local administration of 5FU were investigated by determining the tissue concentration of 5FU, histological appearance of the primary tumor, and lymphocyte subsets of the regional lymph nodes in 23 rectal cancer patients. Twelve patients were treated with 5FU suppositories preoperatively, being the 5FU group, while 11 patients were given no preoperative treatment, being the control group. The 5FU concentrations in the primary tumors were higher than those in the regional lymph nodes and appeared to remain high for an extended period. No histological changes peculiar to the 5FU group were observed in the primary tumors. An analysis of the lymphocyte subsets in the pararectal nodes revealed that Leu2a+15- cells, or cytotoxic T lymphocytes, were significantly decreased in numbers in the 5FU group compared to the control group. These results suggest that the local use of 5FU may not only exert an antitumor effect against rectal cancer, but can also cause the suppression of antitumor immunity in the regional lymph nodes.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 50 条
  • [21] MECHANISM OF POTENTIATION OF ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL AGAINST ADENOCARCINOMA 755 BY L-CYSTEINE
    IIGO, M
    HOSHI, A
    BIOCHEMICAL PHARMACOLOGY, 1986, 35 (05) : 727 - 730
  • [22] MECHANISM OF POTENTIATION OF ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL BY GUANINE RIBONUCLEOTIDES AGAINST ADENOCARCINOMA-755
    IIGO, M
    YAMAIZUMI, Z
    NISHIMURA, S
    HOSHI, A
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (07): : 1059 - 1065
  • [23] IMMUNOSUPPRESSIVE EFFECTS OF 5-FLUOROCYTOSINE AND 5-FLUOROURACIL
    BERENBAUM, MC
    CHEMOTHERAPY, 1979, 25 (01) : 54 - 59
  • [24] Synthesis and antitumor activity of 5-fluorouracil derivatives
    Ozaki, S
    MEDICINAL RESEARCH REVIEWS, 1996, 16 (01) : 51 - 86
  • [25] THE EFFECTS OF 5-FLUOROURACIL IN PATIENTS WITH INCURABLE CANCER
    EYERLY, RC
    CANCER CHEMOTHERAPY REPORTS, 1962, (20): : 89 - 95
  • [26] α-fluoro-β-alanine:: Effects on the antitumor activity and toxicity of 5-fluorouracil
    Cao, SS
    Baccanari, DP
    Rustum, YM
    Davis, ST
    Tansik, RL
    Porter, DJT
    Spector, T
    BIOCHEMICAL PHARMACOLOGY, 2000, 59 (08) : 953 - 960
  • [27] SELECTIVE EXPANSION OF 5,10-METHYLENETETRAHYDROFOLATE POOLS AND MODULATION OF 5-FLUOROURACIL ANTITUMOR-ACTIVITY BY LEUCOVORIN INVIVO
    WRIGHT, JE
    DREYFUSS, A
    ELMAGHARBEL, I
    TRITES, D
    JONES, SM
    HOLDEN, SA
    ROSOWSKY, A
    FREI, E
    CANCER RESEARCH, 1989, 49 (10) : 2592 - 2596
  • [28] PFKP is upregulated in 5-fluorouracil-resistant patients and suppresses the antitumor activity of 5-fluorouracil in colorectal cancer in vitro and in vivo
    Deng, Lili
    Zhao, Yan
    Liu, Wen
    JOURNAL OF CHEMOTHERAPY, 2024, 36 (05) : 422 - 434
  • [29] Suppository delivery of 5-fluorouracil in rectal cancer
    Galandiuk, S
    Wrightson, W
    Marr, L
    Myers, S
    LaRocca, RV
    ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (03) : 270 - 276
  • [30] Preoperative 5-fluorouracil and radiotherapy in rectal cancer
    Tejedor, M
    Valerdi, JJ
    Molina, F
    Arias, F
    Dominguez, MA
    Illarramendi, JJ
    Martinez, E
    Villafranca, E
    Meirino, R
    Pruja, E
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 771 - 771